Multiple Sclerosis News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Molecule Tells Key Brain Cells To Grow Up, Get To Work, Stanford Study Shows
About four out of every 10 cells in the brain are so-called oligodendrocytes. These cells produce the all-important myelin that coats nerve tracts, ensuring fast, energy-efficient transmission of nerve impulses...
Peptimmune Announces Second Grant Of A United States Patent For PI-2301 Peptide Copolymer For Multiple Sclerosis
Peptimmune, Inc. a privately held biotechnology company, announced the grant of US Patent Number 7,655,221 (the '221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases. The '221 patent claims important treatment modalities for PI-2301 and related compounds...
Researchers Find Further Evidence Linking Epstein-Barr Virus And Risk Of Multiple Sclerosis
Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV). This finding implicates EBV as a contributory cause to multiple sclerosis...
Success For Pilot Scheme - Multiple Sclerosis Society
An innovative scheme piloted in Surrey and Sussex, the first of its kind in the country, has had an overwhelmingly positive impact on the lives of people in the area with multiple sclerosis (MS)...
LDN Phase II Trial Results Published - Multiple Sclerosis Society
Results of a phase II clinical trial on the safety and effectiveness of low dose naltrexone (LDN) as a symptom-relief treatment for people with MS have been published in the journal Annals of Neurology. The results of the study suggest that LDN is safe and may have positive effects on the mental quality of life in people with MS; but no effect on a patient's physical quality of life...
Italian Researchers Discover A Possible Onset Mechanism For Multiple Sclerosis
A non-pathogenic bacterium is capable of triggering an autoimmune disease similar to multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work...
Copaxone(R) 15-Year Study In Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy And Safety
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis...
Exercise Helps Protect Brain Of Multiple Sclerosis Patients
Highly fit multiple sclerosis patients perform significantly better on tests of cognitive function than similar less-fit patients, a new study shows. In addition, MRI scans of the patients showed that the fitter MS patients showed less damage in parts of the brain that show deterioration as a result of MS, as well as a greater volume of vital gray matter...
Migraine More Common In Women With MS
Migraine is seen more frequently in women with multiple sclerosis (MS) than those without, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010...
MS Society Launches Major Manifesto Campaign, UK
Today the MS Society launches its 2010 Manifesto in a serious and high profile attempt to encourage the next Government to act upon MS inequalities. The document sets 10 powerful calls for the next Government to act upon...
Add-On Daclizumab Treatment May Be Better In Reducing Multiple Sclerosis Disease Activity Than Interferon Beta Alone
An article published Online First and in the April edition of The Lancet Neurology reports that add-on daclizumab treatment might reduce multiple sclerosis disease activity more than standard interferon beta treatment alone. The article is the work of Dr John W Rose, Neurovirology Research Laboratory, VA Medical Center, Salt Lake City, Utah and University of Utah, USA, and colleagues...
UK Milk Has No Effect On Vitamin D Levels
Recent media reports have covered research announced ahead of the American Academy of Neurology's (AAN) Annual Meeting in April which suggested that milk during pregnancy may lower a baby's risk of developing multiple sclerosis (MS) later in life. The theory from the researchers in Boston, announced in an AAN press release, was based on a survey of American mothers...
Promising Results In First Blinded Study Of Venous Insufficiency Prevalence In Multiple Sclerosis
More than 55 percent of multiple sclerosis patients participating in the initial phase of the first randomized clinical study to determine if persons with MS exhibit narrowing of the extracranial veins, causing restriction of normal outflow of blood from the brain, were found to have the abnormality. The results were reported by neurology researchers at the University at Buffalo...
Preliminary CCSVI Results Announced - Multiple Sclerosis Society
Researchers who have carried out the first randomized clinical study to determine if people with multiple sclerosis (MS) show signs of narrowing of the veins causing restricted blood flow from the brain have said they are 'cautiously optimistic' following the release of preliminary results. The University of Buffalo researchers in New York found that of 280 people with MS, 56...
Blocking Cell Movement For Cancer, MS Treatment
University of Adelaide researchers in Australia are finding new ways to block the movement of cells in the body which can cause autoimmune diseases and the spread of cancer. Led by Professor of Immunology Shaun McColl, the researchers have identified molecular "receptors" on the surface of cells which are involved in helping cells migrate to sites where they can cause disease...
Drinking Milk During Pregnancy May Lower Baby's Risk Of MS
Drinking milk during pregnancy may help reduce your baby's chances of developing multiple sclerosis (MS) as an adult, according to a preliminary study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010...
New Study Finds Specialized Support Programs Can Increase Treatment Adherence And Persistence, Reduce Relapses For People With Multiple Sclerosis
A new study reveals that multiple sclerosis (MS) patients enrolled in a seven-month disease therapy management (DTM) program show greater adherence to injectable MS medications and treatment persistence than patients who receive injectable MS medications through a community pharmacy...
MP Argues Risk Sharing Scheme Not Fit For Purpose
James Gray MP has argued the Risk Sharing Scheme has 'fatal flaws' and is 'hopelessly out of date'. James Gray MP, Chair of the All Party Parliamentary Group on MS, secured a debate on the Risk Sharing Scheme on Tuesday of this week. The purpose of the debate was to consider whether the Scheme has worked to benefit either people living with MS or the NHS...
Multiple Sclerosis: Blacks Have More Severe Symptoms, Decline Faster Than Whites, New Study Shows
Fewer African Americans than Caucasians develop multiple sclerosis (MS), statistics show, but their disease progresses more rapidly, and they don't respond as well to therapies, a new study by neurology researchers at the University at Buffalo has found...
Gordon Brown Receives Prescription Promise 'Wake-Up Call', UK
People across England will be joining forces to demonstrate their outrage at Gordon Brown's failure to act on his promise to abolish prescription charges for people with long-term conditions, by taking part in a simultaneous 'wake-up phone call' to No 10...
The Season Affects Multiple Sclerosis Risk
Previous studies have shown multiple sclerosis (MS) patients are more often born in spring than in any other season, indicating that there is an environmental risk factor for the disease. A paper in the journal Neurology, reviewed for f1000 Medicine by Emmanuelle Waubant and Ellen Mowry, now suggests that this seasonal effect is mediated by the gene HLA-DRB1...
3-Year Mission To Understand And Treat Neurodegenerative Disease
Project A.L.S. (New York, NY) and the Robert Packard Center for ALS Research at Johns Hopkins University (Baltimore, MD) announced that they will partner on P2 ALS, a $15 million initiative designed to advance ALS (Lou Gehrig's disease) research exponentially over the next three years. Project A.L.S...
MS Society Calls On Stem Cell Researchers For Grant Applications
The MS Society has called for researchers and scientists to come forward with research projects investigating the potential benefit of stem cells in multiple sclerosis (MS). A new partnership between the MS Society and the UK Stem Cell Foundation has levered £1million to be specifically ring-fenced for translational, pre-clinical and clinical trials...
Regis Technologies Passes FDA Pre-Approval Inspection For Acorda Therapeutics' Approved Multiple Sclerosis Drug, Ampyraâ„¢
Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S...
PROLOR Biotech Reports Positive Results From Comparative Study Of Its Longer-Acting Version Of Multiple Sclerosis Drug Interferon Beta In Primates
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) reported positive results from a comparative study in primates of its longer-acting version of the multiple sclerosis drug interferon beta (IFN-beta-1a-CTP, referred to as IFN-beta-CTP)...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
